The pricing of weight-loss drugs like Lilly’s Zepbound and Novo’s Wegovy is a pressure point for investors.
Continue Reading
View Comments
Novo Nordisk Stock Could Benefit From Eli Lilly’s Weight-Loss Price Hikes
Published 2 months ago
Aug 15, 2025 at 4:25 PM
Negative
Auto